Enjoy complimentary customisation on priority with our Enterprise License!
The pregabalin market size is forecast to increase by USD 133 million at a CAGR of 3.27% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of conditions such as diabetic peripheral neuropathy and postherpetic neuralgia, which are major indications for this drug. Calcium channels play a crucial role in the transmission of nerve impulses, and Pregabalin, as a calcium channel blocker, is effective in managing neuropathic pain. Furthermore, the growing focus on emerging economies and the increasing preference for alternative treatments, including tablets and capsules, are driving market growth. In the realm of epilepsy drugs, Pregabalin's efficacy in managing neuropathic pain and its favorable patient preference make it a promising contender in the market.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.